The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinomaJiansong Ji, Chenying Lu, Qiaoyou Weng et al.|Research Square|2020Cited by 16
CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathwayZhongwei Zhao, Jiansong Ji, Jingjing Song et al.|Research Square|2020Cited by 3
The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinomaJiansong Ji, Chenying Lu, Bufu Tang et al.|Research Square|2020Cited by 0
The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinomaJiansong Ji, Chenying Lu, Bufu Tang et al.|Research Square|2020Cited by 0
USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bβ via deubiquitinating EGLN3Weiqian Chen, Jiansong Ji, Jingjing Song et al.|Research Square|2021Cited by 0